click below
click below
Normal Size Small Size show me how
FSHN 350- Unit 3
| Question | Answer |
|---|---|
| delta naming system | CX:aΔb,c (# of carbons, how many dbl bonds, where they are) *all double bonds |
| omega naming system | CX:aωb (# of carbons, how many dbl bonds, where they are) *only 1st one |
| desaturase enzymes | 4, 5, 6, 9 |
| elongase enzymes | add carbons in pairs of 2 |
| butyric acid | 4 carbons |
| lauric acid | 12 carbons |
| myristic acid | 14 carbons |
| palmitic acid | 16 carbons |
| stearic acid | 18 carbons |
| when are trans fats dangerous? | low as 1-3% of total calories |
| first two enzymes in lipid digestion | lingual lipase, gastric lipase |
| bile salts are synthesized by | hepatocytes |
| how do long chain/lysophospholipids/cholesterol enter enterocyte? | micelle |
| how do short and medium chain enter blood? | albumin |
| chylomicron | transport of dietary TG from intestines to peripheral tissues |
| VLDL | transport of endogenous TG from liver to peripheral tissues |
| LDL | transport of cholesterol to peripheral tissues |
| HDL | transport of cholesterol to liver |
| three apolipoproteins on CM | B48, E, C2 |
| apolipoprotein B48 function | stabilizes CM in aq environment |
| apolipoprotein C2 function | activates LPL |
| apolipoprotein E function | for uptake into liver by LDL receptor |
| three apolipoproteins on VLDL | B100, E, C2 |
| apolipoprotein B100 function | LDL recognition |
| Familial Hypercholesterolemia | mutation in LDL receptor or apo B100 |
| Lipoprotein lipase deficiency | high CM and high VLDL |
| oleic acid | C18:1Δ9 |
| linoleic acid | C18:2Δ9,12 |
| a-linolenic acid | C18:3Δ9,12,15 |
| if more than one double bond is present, they occur every | three carbons |
| arachidonic acid | C20:4Δ5,8,11,14 |
| EPA | C20:5Δ5,8,11,14,17 |
| DHA | C22:6Δ4,7,10,13,16,19 |
| cholesterol ester | cholesterol w/ ester and fatty acid tail |
| chylomicrons are composed mostly of | triacylglyerols |
| HDLs are composed mostly of | proteins |
| LDLs are composed mostly of | cholesterol esters |
| LDL receptor | recognizes apo B100 on LDL particles; also recognizes apo E on CM and IDL |
| Tangier disease | defect in ABCA1; cholesterol builds up in macrophage |
| two fates of glycerol | oxidized through glycolysis or converted to glucose through gluconeogenesis |
| how many ATP per beta oxidation cycle? | 5 |
| how many ATP per acetyl coA molecule? | 12 |
| beta oxidation of unsaturated FAs | for each double bond, 2 fewer ATP produced (1 fewer FADH) |
| beta oxidation of odd-chained FAs | propionyl coA-> succinyl coA *converted to glucose so this is glycogenic! |
| three steps of lipogenesis | lipogenesis, desaturation/elongation, esterification |
| enzyme in fatty acid synthesis | fatty acid synthase |
| ACC knockout mice | continuous beta oxidation; won't make malonyl coA |
| FAS knockout mice | more sensitive to insulin; less likely to get fat |
| three types of eicosanoids | prostaglandins, thomboxanes, leukotrienes |
| two pathways from linoleic acid | cyclic (cyclooxygenase), linear (lipoxygenase) |
| n6 fatty acids cause | inflammation |
| n3 fatty acids cause | anti-inflammatory effects |
| LDL CVD cutoff | >130 mg/dL |
| HDL CVD cutoff | <40 mg/dL |
| serum cholesterol CVD cutoff | >200 mg/dL |
| seven countries study | ancel, keys et al *correlation between cholesterol/fat/sat fat and CVD *inverse correlation between PUFA/MUFA |
| CRP and CVD | high CRP (inflammatory protein)-> increased risk of CVD |
| common soil hypothesis | CVD and diabetes are unrelated, but these people are prone to health problems based on lifestyle |
| ___% of CVD occurs in people w/ less than 200mg/dL total cholesterol | 35% |